Mabwell (shanghai) Bioscience Co., Ltd. Class ASSE: 688062

Announcement on Voluntary Disclosure of Acceptance Supplementary Application for Increasing the Indications of Denosumab Injection (MAIWEIJIAN)

· Issued by Mabwell (shanghai) Bioscience Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Voluntary Disclosure of Acceptance Supplementary Application for Increasing the Indications of Denosumab Injection (MAIWEIJIAN)

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Company analysis